Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs

Yanong D. Wang,steven w johnson,Dennis Powell,John P. McGinnis,Miriam Miranda,Sridhar K. Rabindran

DOI: https://doi.org/10.1016/j.bmcl.2005.05.127

IF: 2.94

2006-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:The synthesis of a series of novel tricyclic thieno[2,3-d]pyrimidin-4(1H)-one-based analogs and their anti-proliferative activities are described.

What problem does this paper attempt to address?

Inhibition of Tumor Cell Proliferation by Thieno[2,3-d]pyrimidin-4(1H)-one-based Analogues.

Yanong D. Wang,Steven Johnson,Dennis Powell,John P. McGinnis,Miriam Miranda,Sridhar K. Rabindran

DOI: https://doi.org/10.1002/chin.200604158

2006-01-01

ChemInform

Abstract:For Abstract see ChemInform Abstract in Full Text.
Inhibition of Tumor Cell Proliferation by Thieno[2,3‐d]pyrimidin‐4(1H)‐one‐based Analogues.

Yanong D. Wang,Steven W. Johnson,Dennis Powell,John P. McGinnis,Miriam Miranda,Sridhar K. Rabindran

DOI: https://doi.org/10.1002/chin.200604158

2006-01-01

ChemInform

Abstract:For Abstract see ChemInform Abstract in Full Text.
Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs.

Taijie Chen,Yu Luo,Youhong Hu,Bo Yang,Wei Lu

DOI: https://doi.org/10.1016/j.ejmech.2013.04.008

IF: 7.088

2013-01-01

European Journal of Medicinal Chemistry

Abstract:A series of 1,6-diaryl pyridin-2(1H)-one analogs were designed and synthesized via consecutive Chan–Lam coupling and Suzuki coupling. These novel compounds were evaluated for their antiproliferative activity against two tumor cell lines (SKOV-3 and HepG2). Compounds 1b, 1c, 1e and 1f displayed comparable in vitro cytotoxicity with taxol, while their in vivo antitumor activity was less effective than taxol. In addition, cell cycle assay indicated that these 1,6-diaryl pyridin-2(1H)-one compounds induced cell cycle arrest in the G1/M phase in the HepG2 cell line.
New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

Jian-Guo Yang,Fu-You Pan

DOI: https://doi.org/10.2174/157017807780414181

2007-01-01

Letters in Organic Chemistry

Abstract:Fifteen new 3-[(4-hydroxy-6-methly-2(1H)-pyridinones)-3-yl]-4-substituted- (1H)-1,2,4-triazole-5-thione compounds were synthesized from methyl 4-hydroxy-6- methyl-2-oxo-1,2-dihydropyridine-3-carboxylate in good overall yields by four step reactions. Molecular structure of these compounds was confirmed by IR, NMR, MS, elemental analysis and X-ray diffraction. Their antitumor activities were evaluated in vitro by the SRB and MTT methods. The results show that there are two compounds which are highly effective against KB cells and one compound which is highly effective against Bel-7402 cells.
Synthesis And Anti-Tumor Activity Of 4-(Methoxyl Thienyl)-3-(Substituted Benzoyl) Pyrroles

Kai Zhao,Shuai Wang,Xiaoping Zhan,Zenglu Liu,Zhenmin Mao

DOI: https://doi.org/10.6023/cjoc201610044

2017-01-01

Chinese Journal of Organic Chemistry

Abstract:33 novel 4-substituted thienyl pyrrole compounds were synthesized via replacement, Vilsmeier-Hack, aldol condensation and Van Leusen pyrrole reaction using 2-methoxythiophen, 3-methoxythiophene, 3,4-dibromothiophene and substituted acetophenone as raw materials. The structures of all target compounds were characterized by 1H NMR, 13C NMR and HRMS, meanwhile the cell proliferation inhibition efficacy was estimated against CHO, HCT-116, MGC80-3, SGC-7901 and HUVEC cell lines. The results revealed that some target compounds exhibited strong (IC50 <= 20 mu mol/L) or moderate (20 mu mol/L<IC50 <= 50 mu mol/L) proliferation inhibition efficacy against tumor cells, meanwhile no significant inhibition activity on HUVEC, which indicated that these compounds had high selectivity. Herein, some compounds showed strong or moderate inhibition efficacy against MGC80-3. The IC50 values of [4-(3,4-dimethoxythiophen-2-yl)-1H-pyrrol-3-yl](4-phenylphenyl)methanone (4a-2) and [4-(3,4-dimethoxythiophen-2-yl)-1H-pyrrol-3-yl](3-bromophenyl) methanone (4a-7), were 8.6 and 8.5 mu mol/L against MGC80-3, respectively, and the IC50 value of 4a-7 was 20.0 mu mol/L against HCT-116. Both compounds 4a-2 and 4a-7 exhibited moderate inhibition efficacy against SGC-7901.
Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues As Potent Cytotoxic Agents.

Xiaoming Yang,Qian Shi,Yi-Nan Liu,Guiyu Zhao,Kenneth F. Bastow,Jau-Chen Lin,Shuenn-Chen Yang,Pan-Chyr Yang,Kuo-Hsiung Lee

DOI: https://doi.org/10.1021/jm9009263

IF: 8.039

2009-01-01

Journal of Medicinal Chemistry

Abstract:Nineteen new phenanthrene-based tylophorine analogues with various functional groups on the piperidine moiety were designed, synthesized, and evaluated for in vitro anticancer activity against four human tumor cell lines. Analogues 15 and 21 showed approximately 2-fold enhanced inhibitory activity as compared with our prior lead compound (PBT-1). Analogues 23 and 24 with S- and R-configured substituents, respectively, at the piperidine 3'-position exhibited comparable cytotoxicity to that of PBT-1. Furthermore, mechanistic studies to investigate the effects of the new compounds on Akt protein in lung cancer cells and the NF-kB signaling pathway suggested that the compounds may exert their inhibitory activity on tumor cells through inhibition of activation of both Akt and NF-kB signaling pathway.
Synthesis and Anti-Tumor Activity of 1,4-Dihydrothieno[3',2':5,6]Thiopyrano[4,3-c]pyrazole-3-carboxylic Amide Derivatives

Rui Sun,Jing Song,Hui Zhao,Chun-Li Yan,Ai-Jun Zhang,Koirala Diwa,Da-Wei Li,Chun Hu

DOI: https://doi.org/10.5246/jcps.2011.01.004

2011-01-01

Journal of Chinese Pharmaceutical Sciences

Abstract:Five 1,4-dihydrothieno[3′,2′:5,6]thiopyrano[4,3-c]p5Tazole-3-carboxylic amide derivatives were synthesized from 2-mercaptothiophene via a six-step procedure. The prepared compounds were initially evaluated for their antiproliferative activity using the estrogen receptors expressing MCF-7 human mammary tumor cell line in vitro. All of the prepared compounds showed moderate anti-tumor activity.
Preparation of 2-Pyridone-containing Tricyclic Alkaloid Derivatives As Potential Inhibitors of Tumor Cell Proliferation by Regioselective Intramolecular N- and C-acylation of 2-Pyridone.

SZ Wang,LY Cao,HJ Shi,YM Dong,JW Sun,YF Hu

DOI: https://doi.org/10.1248/cpb.53.67

2005-01-01

Chemical and Pharmaceutical Bulletin

Abstract:A novel and practical preparation of 2-pyridone-containing tricyclic alkaloid derivatives was developed. By regioselective intramolecular N- and C-acylation of 2-(4-aryl-2-pyridon-6-yl)benzoic acid, a pair of structural isomers 2-aryl pyrido[2,1-a]isoindole-4,6-diones and 4-aryl 1-methyl-1H-indeno[1,2-b]-pyridine-2,5-diones, as potential inhibitors of tumor cell proliferation, were prepared respectively.
Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Xuefen Tao,Yongzhou Hu

DOI: https://doi.org/10.2174/157340610791321505

2010-01-01

Medicinal Chemistry

Abstract:A novel series of 2-aryl-1, 2, 4-triazolo [1, 5-a] pyridine derivatives have been synthesized and evaluated for their cytotoxic activities in vitro against Human ovarian cancer cell line (HO-8910) and Human liver cancer cell line (Bel 7402). Most compounds showed high or mediate activity against the cancer cell lines when compared with Cisplatin. Two of them were tested the apoptosis on Bel 7402.
Synthesis and in vitro cytotoxic evaluation of novel N -(3,4,5-trimethoxyphenyl)pyridin-2( 1H )-one derivatives

Taijie Chen,Yu Luo,Li Sheng,Jia Li,Youhong Hu,Wei Lu

DOI: https://doi.org/10.1007/s11030-013-9442-1

2013-01-01

Molecular Diversity

Abstract:series of novel N -(3,4,5-trimethoxyphenyl)pyridin-2( 1H )-one derivatives were designed, synthesized, and evaluated for their in vitro cytotoxicity against human colon cancer cells HCT-116. The key steps involved consecutive Chan–Lam- and Buchwald–Hartwig couplings. Most of these C-6 substituted pyridone derivatives showed moderate antiproliferative activity. The preliminary SAR indicated that the conformationally restricted pyridones exhibited more potent cytotoxicity than the flexible counterparts. In addition, cell cycle analysis of the selected compounds 4b and e showed a G2/M arrest, suggesting a possible antitubulin mechanism for these novel pyridone derivatives.
Synthesis and Evaluation of Biological Activities of Thieno-[2,3- d ]-pyrimidine Derivatives

Yue Guo,Chenglu Qian,Rongrong Yang,Zhongfei Han,Guoxiang Sun,Yaquan Sun

DOI: https://doi.org/10.21577/0103-5053.20240198

2024-11-09

Journal of the Brazilian Chemical Society

Abstract:Guo, Yue ; Qian, Chenglu ; Yang, Rongrong ; Han, Zhongfei ; Sun, Guoxiang ; Sun, Yaquan ; A series of novel thieno[2,3-d]pyrimidine derivatives were designed, synthesized and evaluated for their biological ability. 2-Amino-4,7-dihydro-5H-thieno[2,3-d]pyrano-3-cyanonitrile was synthesized by Gewald reaction using pyranone as substrate, malonitrile and sulfur powder as raw materials and triethylamine as base at room temperature. Subsequent amination with N,N-dimethylformamide dimethyl acetal (DMF-DMA) gave N'-(3-cyano-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)-N,N-dimethylmethanimidamide. In this article, the 23 thieno[2,3-d] pyrimidines were obtained by Dimroth rearrangement condensation with different anilines, 16 of them being new compounds. Meanwhile, all compounds were assessed for breast cancer MDA-MB-231 cell line bioactivity with paclitaxel (PTX) as the positive control, and all compounds in the series showed inhibitory effects on breast cancer cell MDA-MB-231. The IC50 of compound l against MDA-MB-231 is 27.6 μM, which is similar to that of PTX with an IC50 of 29.3 μM. This means that compound l exhibits comparable inhibitory activity to PTX in MDA-MB-231 cells and may be considered as a potential anti-MDA-MB-231 inhibitor.

chemistry, multidisciplinary
Design, Synthesis, and Biological Evaluation of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as Microtubule Targeting Agents

Farhana Islam,Arpit Doshi,Andrew J. Robles,Tasdique M. Quadery,Xin Zhang,Xilin Zhou,Ernest Hamel,Susan L. Mooberry,Aleem Gangjee

DOI: https://doi.org/10.3390/molecules27010321

IF: 4.6

2022-01-05

Molecules

Abstract:A series of eleven 4-substituted 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines were designed and synthesized and their biological activities were evaluated. Synthesis involved the Gewald reaction to synthesize ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ring, and SNAr reactions. Compound 4 was 1.6- and ~7-fold more potent than the lead compound 1 in cell proliferation and microtubule depolymerization assays, respectively. Compounds 4, 5 and 7 showed the most potent antiproliferative effects (IC50 values < 40 nM), while compounds 6, 8, 10, 12 and 13 had lower antiproliferative potencies (IC50 values of 53–125 nM). Additionally, compounds 4–8, 10 and 12–13 circumvented Pgp and βIII-tubulin mediated drug resistance, mechanisms that diminish the clinical efficacy of paclitaxel (PTX). In the NCI-60 cell line panel, compound 4 exhibited an average GI50 of ~10 nM in the 40 most sensitive cell lines. Compound 4 demonstrated statistically significant antitumor effects in a murine MDA-MB-435 xenograft model.

chemistry, multidisciplinary,biochemistry & molecular biology
Rational synthesis and evaluation of 2,4-diamino-thieno[2,3-d]pyrimidines as antitumor agents

Yumeng Gao,Ainv Zhang,Li Li,Fengxu Wu,Yanggen Hu

DOI: https://doi.org/10.1016/j.jscs.2023.101794

IF: 4.712

2023-12-23

Journal of Saudi Chemical Society

Abstract:Based on structure-guided of thieno[2,3-d]pyrimidine skelecton functionalities and computer-aided drug development strategy, a series of novel 2,4-diamino-thieno[2,3-d]pyrimidine derivatives were designed and synthesized, and their structure confirmed by 1 H NMR, 13 C NMR and HR-MS. All synthesized compounds were evaluated for antitumor activities against hepatic carcinoma (HepG2) cell lines in vitro, and results showed that all the target compounds exhibited potent antitumor activity. Preliminary comparison indicated that a more bulky substituent group at the C-4 position, and at the same time the introduction of 3-Cl on the phenyl ring with 4-methyl group on the C-2 position of thieno[2,3-d]pyrimidine have remarkable influence on activity. One of the expected target compound 5i showed the best inhibition activities against HepG2 with IC 50 value 0.17μmol/L. To further investigate the structure-activity relationship, the docking experiment of 5i , 5j , 5o and Gefitinib on EGFR were performed. The docking results displayed that compound 5i was able to be tightly embedded in the active pocket of EGFR and the binding energy is most negative with EGFR, which demonstrating that compound 5i can be take a potential lead compound for further lucubrate.

chemistry, multidisciplinary
Synthesis, SAR Study and Biological Evaluation of Novel Pyrazolo[1,5-A]pyrimidin-7-yl Phenyl Amides As Anti-Proliferative Agents

Yanong D. Wang,Erick Honores,Biqi Wu,Steve Johnson,Dennis Powell,Miriam Miranda,John P. McGinnis,Carolyn Discafani,Sridhar K. Rabindran,Wendy Cheng,Girija Krishnamurthy

DOI: https://doi.org/10.1016/j.bmc.2008.12.046

IF: 3.461

2008-01-01

Bioorganic & Medicinal Chemistry

Abstract:Checkpoint deficiency of malignant cells can be exploited in cancer drug discovery. Compounds that selectively kill checkpoint-deficient cells versus checkpoint-proficient cells can be utilized to preferentially target tumor cells, while sparing normal cells. The protein p21Wafl/Cipl/Sdi1 (hereafter referred to as p21) inhibits progression of the cell cycle by inhibiting the activity of G1 kinases (cyclin D/cdk4 and cyclin E-cdk2) and the G2 kinase (cyclin B/cdkl) in response to DNA damage or abnormal DNA content. The expression of p21 is often low in human cancer cells due to frequent loss of the upstream activator, p53, and is associated with poor prognosis in some cancer patients. Using an isogenic pair of cell lines, HCT116 (p21+/+) and 80S14 (p21−/−), we have disclosed previously a novel series of pyrazolo[1,5-a]pyrimidines that preferentially kill the p21-deficient cells. We will present the synthesis, biological activities and SAR study of a series of pyrazolo[1,5-a]pyrimidines with an optimized phenyl amide moiety at the C-7 position. The mechanism of action of these compounds will also be discussed.
Synthesis And In Vitro Cytotoxic Evaluation Of Novel -(3,4,5-Trimethoxyphenyl)Pyridin-2()-One Derivatives

Taijie Chen,Yu Luo,Li Sheng,Jia Li,Youhong Hu,Wei Lu

DOI: https://doi.org/10.1007/s11030-013-9442-1

2013-01-01

Molecular Diversity

Abstract:A series of novel -(3,4,5-trimethoxyphenyl)pyridin-2()-one derivatives were designed, synthesized, and evaluated for their in vitro cytotoxicity against human colon cancer cells HCT-116. The key steps involved consecutive Chan-Lam- and Buchwald-Hartwig couplings. Most of these C-6 substituted pyridone derivatives showed moderate antiproliferative activity. The preliminary SAR indicated that the conformationally restricted pyridones exhibited more potent cytotoxicity than the flexible counterparts. In addition, cell cycle analysis of the selected compounds 4b and e showed a G2/M arrest, suggesting a possible antitubulin mechanism for these novel pyridone derivatives.
Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy

Chengyong Wu,Lele Zhang,Zhilan Zhou,Lun Tan,Zhijia Wang,Cuiyu Guo,Yuxi Wang

DOI: https://doi.org/10.1016/j.ejmech.2024.116649

2024-10-05

Abstract:Guided by the X-ray cocrystal structure of the lead compound 4a, we developed a series of thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines demonstrating potent antiproliferative activity against four tumor cell lines. Two analogs, 13 and 25d, exhibited IC50 values around 1 nM and overcame P-glycoprotein (P-gp)-mediated multidrug resistance (MDR). At low concentrations, 13 and 25d inhibited both the colony formation of SKOV3 cells in vitro and tubulin polymerization. Furthermore, mechanistic studies showed that 13 and 25d induced G2/M phase arrest and apoptosis in SKOV3 cells, as well as dose-dependent inhibition of tumor cell migration and invasion at low concentrations. Most notably, the X-ray cocrystal structures of compounds 4a, 25a, and the optimal molecule 13 in complex with tubulin were elucidated. This study identifies thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines as representatives of colchicine-binding site inhibitors (CBSIs) with potent antiproliferative activity.
3-Aryl Β-Carbolin-1-ones As a New Class of Potent Inhibitors of Tumor Cell Proliferation: Synthesis and Biological Evaluation

SZ Wang,YM Dong,XY Wang,XY Hu,JO Liu,YF Hu

DOI: https://doi.org/10.1039/b412921k

2005-01-01

Organic & Biomolecular Chemistry

Abstract:A novel three-step synthesis of 3-aryl β-carbolin-1-ones from non-indole starting materials has been developed. The two nitrogen atoms in β-carbolin-1-one were introduced efficiently by Michael addition of ethyl acetamidocyanoacetate to chalcone. The desired pyridone and indole rings were assembled by an intramolecular ketone–nitrile annulation mediated by aqueous HCl–HOAc and a Cu(I)-catalyzed intramolecular N-arylation of the amide, respectively. The target compounds were found to possess significant activity against tumor cell proliferaton.
Synthesis and Anticancer Activity Evaluation of a Series of [1,2,4]Triazolo[1,5-A]pyridinylpyridines in Vitro and in Vivo

Xiao-Meng Wang,Jing Xu,Yi-Ping Li,Huan Li,Cong-Shan Jiang,Guang-De Yang,She-Min Lu,San-Qi Zhang

DOI: https://doi.org/10.1016/j.ejmech.2013.06.052

IF: 7.088

2013-01-01

European Journal of Medicinal Chemistry

Abstract:A series of [1,2,4]triazolo[1,5-a]pyridinylpyridines were synthesized and characterized. Their antiproliferative activities in vitro were evaluated by MTT against three human cancer cell lines including HCT-116, U-87 MG and MCF-7 cell lines. The SAR of target compounds was preliminarily discussed. The compounds 1c and 2d with potent antiproliferative activities were tested for their effects on the AKT and p-AKT(473). The anticancer effect of 1c was evaluated in mice bearing sarcoma S-180 model. The results suggest that the title compounds are potent anticancer agents.
Syntheses, Molecular Targets and Antitumor Activities of Novel Triptycene Bisquinones and 1,4-Anthracenedione Analogs

Duy H Hua,Kaiyan Lou,Srinivas K Battina,Huiping Zhao,Elisabeth M Perchellet,Yang Wang,Jean-Pierre H Perchellet

DOI: https://doi.org/10.2174/187152006777698141

IF: 2.8

2006-01-01

Anti-Cancer Agents in Medicinal Chemistry

Abstract:Novel substituted triptycene bisquinones and 1, 4-anthracenediones were synthesized and screened for their anti-cancer activities. A number of analogs were synthesized utilizing various synthetic transformations and found to elicit interesting antitumor effects. Analogs included water-soluble pro-drugs and ammonium salts. These potent antitumor drugs are DNA topoisomerase inhibitors that induce DNA strand breaks, inhibit DNA, RNA and protein syntheses and reduce tumor cell proliferation in the nanomolar range in vitro. They induce cytochrome c release, caspase-9, -3 and -8 activities, poly(ADP)-ribose polymerase-1 (PARP) cleavage, and internucleosomal DNA fragmentation by a mechanism which involves caspase-2 activation but not Fas signaling. Moreover, these drugs remain effective in multidrug-resistant tumor cells and have the advantage of blocking nucleoside transport and inducing a rapid loss of mitochondrial transmembrane potential. Based on their effects in tumor cells and isolated mitochondria, it is hypothesized that these drugs might, directly and indirectly, target components of the permeability transition pore to induce mitochondrial permeability transition and the release of proapoptotic factors. This review provides a summary of synthetic efforts and mechanistic endeavor.
Identification of Thiazolo[5,4-D]pyrimidine Derivatives As Potent Antiproliferative Agents Through the Drug Repurposing Strategy

Zhong-Hua Li,Ji Zhang,Xue-Qi Liu,Peng-Fei Geng,Jin-Lian Ma,Bo Wang,Tao-Qian Zhao,Bing Zhao,Hao-Ming Wei,Chao Wang,Dong-Jun Fu,Bin Yu,Hong-Min Liu

DOI: https://doi.org/10.1016/j.ejmech.2017.04.056

IF: 7.088

2017-01-01

European Journal of Medicinal Chemistry

Abstract:A series of thiazolo[5,4-d]pyrimidine derivatives were synthesized and evaluated for their antiproliferative activities on three cancer cell lines. The structure-activity relationship studies were conducted through the variation in the three regions of the thiazolo-pyrimidine core. Substitution with morpholine led to compound 24, which exerted the most potent antiproliferative activity as well as good selectivity between cancer and normal cells (IC50 values of 1.03 μM against MGC803 and 38.95 μM against GES-1). In addition, compound 24 inhibited the colony formation and migration of MGC803 as well as induced apoptosis. Western blot experiments indicated the expression changes of apoptosis-related proteins, including up-regulation of Bax and caspase-3/9, as well as down-regulation of Bcl-2.

Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs

Inhibition of Tumor Cell Proliferation by Thieno[2,3-d]pyrimidin-4(1H)-one-based Analogues.

Inhibition of Tumor Cell Proliferation by Thieno[2,3‐d]pyrimidin‐4(1H)‐one‐based Analogues.

Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs.

New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

Synthesis And Anti-Tumor Activity Of 4-(Methoxyl Thienyl)-3-(Substituted Benzoyl) Pyrroles

Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues As Potent Cytotoxic Agents.

Synthesis and Anti-Tumor Activity of 1,4-Dihydrothieno[3',2':5,6]Thiopyrano[4,3-c]pyrazole-3-carboxylic Amide Derivatives

Preparation of 2-Pyridone-containing Tricyclic Alkaloid Derivatives As Potential Inhibitors of Tumor Cell Proliferation by Regioselective Intramolecular N- and C-acylation of 2-Pyridone.

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Synthesis and in vitro cytotoxic evaluation of novel N -(3,4,5-trimethoxyphenyl)pyridin-2( 1H )-one derivatives

Synthesis and Evaluation of Biological Activities of Thieno-[2,3- d ]-pyrimidine Derivatives

Design, Synthesis, and Biological Evaluation of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as Microtubule Targeting Agents

Rational synthesis and evaluation of 2,4-diamino-thieno[2,3-d]pyrimidines as antitumor agents

Synthesis, SAR Study and Biological Evaluation of Novel Pyrazolo[1,5-A]pyrimidin-7-yl Phenyl Amides As Anti-Proliferative Agents

Synthesis And In Vitro Cytotoxic Evaluation Of Novel -(3,4,5-Trimethoxyphenyl)Pyridin-2()-One Derivatives

Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy

3-Aryl Β-Carbolin-1-ones As a New Class of Potent Inhibitors of Tumor Cell Proliferation: Synthesis and Biological Evaluation

Synthesis and Anticancer Activity Evaluation of a Series of [1,2,4]Triazolo[1,5-A]pyridinylpyridines in Vitro and in Vivo

Syntheses, Molecular Targets and Antitumor Activities of Novel Triptycene Bisquinones and 1,4-Anthracenedione Analogs

Identification of Thiazolo[5,4-D]pyrimidine Derivatives As Potent Antiproliferative Agents Through the Drug Repurposing Strategy